Recent Finacing
Recent Raise
OMass develops small-molecule therapeutics using the OdyssION platform, combining native mass spectrometry, novel biochemistry and custom chemistry to interrogate protein interactions and target solute carriers, complex-bound proteins and GPCRs.
